Speakers

Glareh Azadi

Principal Scientist

Abbvie

Laszlo Radvanyi

Chairman Scientific Advisory Board

Proviva Therapeutics

Richard Klemke

CSO

Cytonus Therapeutics, Inc

Sara Ferrando-Martinez

Principal Scientist & Head of Clinical Sciences

NeoImmuneTech Inc.

Giulio Paciotti

CSO

CytImmune Sciences

John Cini

Chief Scientific Officer & Co-Founder

Sonnet BioTherapeutics Inc.

Jonathan Davis

Vice President - Innovation & Strategy

Invenra Inc.

Roberto De Luca

Head of Therapeutic Antibodies

Philochem

Asaf Maoz

Hematology & Oncology fellow

Brigham & Women's - Dana Farber Cancer Institute

Irena Adkins

Director - Pharmacology

SOTIO

Nathan Matthewson

Cell Therapy Lead

Asher Biotherapeutics Inc.

Stephen Connelly

Co-Founder, CSO

Equillium Inc.

Matthew Ling-Hon Chu

Associate Director - Protein Engineering

Astellas Venture Management LLC

Omid Veiseh

Co-Founder

Avenge Bio

Raymond Moniz

Associate Director- Discovery & Translational Immunology

Cue Biopharma

Thierry Giffon

Scientist III Immuno Oncology

IGM Biosciences

Byung Lee

Senior Vice President & Chief Scientific Officer

NeoImmuneTech Inc.

David Oarr

President

CytImmune Sciences

Ekta Patel

Director - Translational Biomarkers

Xilio Therapeutics Inc.

Fahar Merchant

President & Chief Executive Officer

Medicenna Therapeutics

Gaurav Agrawal

Associate Director, Market Development

Eurofins DiscoverX

Giovanni Abbadessa

Global Head of Oncology Early Development

Sanofi Genzyme

Paula Fraenkel

Executive Director & Global Project Lead

AstraZeneca

Solomon Slim

Lead Cytokine Research Analyst

Beacon Targeted Therapies

Brian Soper

Senior Scientific, Engagement Manager

The Jackson Laboratory

Jeff Nelson

Product Manager

Promega

Karsten Sauer

VP of Immunology

Repertoire Immune Medicines

Lucas Donigian

Senior Director Business Development & Alliance Management

Zymeworks